Society for Heart Attack Prevention and Eradication

SHAPE Summit Presentations

AHA 2012 - Los Angeles, CA

 View Agenda

 if your browser asks for a password, please click cancel and the PowerPoint presentation will open

  

 

Daniel Berman, M.D.

Director of Cardiac Imaging and of Nuclear Cardiology
at Cedars-Sinai, Los Angeles, CA
Professor of Medicine at UCLA School of Medicine, Los Angeles, CA

Opening Remarks 

 


 

 Morteza Naghavi, M.D.

Founder of SHAPE and Executive Chairman of the SHAPE Task Force

Moment of Silence Honoring the Late Dr. S Ward Casscells, a Pioneer in Early Detection of the "Vulnerable Patient"

 

Power
Point
Slides

Matthew Budoff, M.D. 

Director of Cardiac CT Imaging, Los Angeles Biomedical Research Institute: Professor of Medicine, Harbor UCLA Medical Center, Torrance, CA

Latest developments in non-invasive imaging of atherosclerosis using coronary calcium 

 

Power
Point
Slides
 

 

Tasneem Naqvi, M.D.

Director, Echocardiography Services, Medical Director, Non Invasive Diagnostic Services, University of Southern California, Cardiac amd Vascular Institute,                   Los Angeles, CA

Latest developments in non-invasive imaging of atherosclerosis using carotid ultrasound (CIMT and Plaque) In the New Era of PCI

Power
Point
Slides

 

Jagat Narula, M.D.

Professor of Medicine, Philip J. and Harriet L. Goodhart Chair in Cardiology, Director of Cardiovascular Imaging Program, Mount Sinai's Zena and Michael A. Wiener Cardiovascular Health; Associate Dean for Global Health, Mount Sinai School of Medicine, New York, NY

Coronary CT Angiography

Power
Point
Slides

 

P.K. Shah, M.D.

Director, Division of Cardiology
Director, Oppenheimer Atherosclerosis Research Center
Shapell and Webb Family Chair in Clinical Cardiology
Professor, Cedars-Sinai Professorial Series

 


 

 

Erling Falk, M.D., Ph.D. 

Chief of SHAPE Guidelines Editorial Committee Professor of Pathology and Cardiology, Aarhus University Hospital (Skejby), Aarhus, Denmark

HRP BioImage Study: Preliminary Observations
How much of the variability in subclinical arterial disease can be explained by risk factors?
 

 aha2012-falk-still

Presentation under embargo until HRP Trial
results are released
 

 

Alan Rozanski, M.D.

Interim Chief, Division of Cardiology, St. Luke's-Roosevelt Hospital Professor of Medicine, Columbia University College of Physicians and Surgeons

Lessons Learned from the EISNER Trial

Power
Point
Slides

 

Harvey Hecht, M.D.

Professor of Medicine, Associate Director of Cardiac Imaging, The Mount Sinai Medical Center, New York, NY

Planned NIH Study: Comparing SHAPE with Status Quo

Power
Point
Slides

 

Raimund Erbel, M.D.

Professor of Medicine, University of Essen
Director of Department of Cardiology, West German Heart Center, Essen, Germany

Lessons learned from the Heinz Nixdorf Recall Study

Power
Point
Slides

 

Robert Superko, M.D.

Chief of Medical Affairs – Celera
Adjunct Professor, Mercer University School of Pharmaceutical Sciences, Atlanta, GA

What is the Role of Genetics and Biomarkers in Prevention?

Power
Point
Slides

 

 

 

 

CERTIFIED PROFESSIONALS

Become a SHAPE Certified
Medical Professional

Read More +

CENTER OF EXCELLENCE

Become a SHAPE Certified
Center of Excellence

Read More +

CIMT TRAINING

Carotid Intima Media Thickness ultrasound training.

Read More +